Funding for this research was provided by:
Bioverativ Therapeutics (PO 5001879)
Article History
Accepted: 13 March 2019
First Online: 22 March 2019
Compliance with ethical standards
:
: Dr. Schwartz and Ms. Zhang declare that they have no conflict of interest. Dr. Su is an employee and shareholder of Bioverativ at the time the study was conducted.
: Informed consent was obtained from all individual participants included in the study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.